deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT01581333

Study to Reduce Duration of Antibiotic Therapy in Haematological Patients With Fever and Neutropenia (HOWLONG)

Randomized Open Label Clinical Trial Directed to Optimize the Duration of Empirical Antimicrobial Therapy in Haematologic Patients With Febrile Neutropenia

Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Conditions Febrile Neutropenia
Interventions Empirical antimicrobial treatment discontinuation Standard empirical antimicrobial treatment discontinuation
Updated 6 times since 2017 Last updated: Oct 31, 2017 Started: Apr 30, 2012 Primary completion: May 31, 2016 Completion: Jun 30, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Febrile Neutropenia and is currently completed. Fundación Pública Andaluza para la gestión de la Investigación en Sevilla leads this study, which shows 6 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Nov 2017 · 10 months · monthly snapshotCompleted~Nov 2017 – ~Jun 2018 · 7 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  5. Nov 2017 — Jun 2018 [monthly]

    Completed PHASE4

▶ Show 1 earlier version

  1. Jan 2017 — Nov 2017 [monthly]

    Completed PHASE4

    First recorded

Apr 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Data source: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations